Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Martin Avenue Pharmacy, Inc.
WARNING LETTER
•Martin Avenue Pharmacy, Inc.•July 21, 2014

Martin Avenue Pharmacy, Inc. – FDA Warning Letter, Jul 21, 2014

Record Details

The FDA issued a Warning Letter to Martin Avenue Pharmacy following a June-July 2014 inspection, identifying significant violations. The pharmacy was found to be producing drug products without valid patient-specific prescriptions and compounding domperidone, which lacks an applicable USP/NF monograph, FDA approval, or inclusion on a Secretary's list under FDCA section 503A(b)(1)(A)(i)(III).

Serious deficiencies in sterile drug production were observed, including using non-sterile materials for cleaning, not using sporicidal agents, inadequate environmental monitoring, poor aseptic technique by operators (touching container interiors with non-sterile gloves, using contaminated vial holders), and failure to demonstrate adequate protection of ISO 5 areas. These issues render products adulterated under FDCA section 501(a)(2)(A).

The firm's compounded drugs without valid prescriptions and domperidone products are deemed unapproved new drugs (violating FDCA sections 505(a) and 301(d)) and misbranded (violating FDCA sections 502(f)(1) and 301(a)). Furthermore, the manufacture of drugs without valid prescriptions subjects the firm to CGMP regulations (21 CFR Parts 210 and 211), with numerous violations cited, including inadequate procedures for preventing microbiological contamination, environmental monitoring, cleaning/disinfection, equipment maintenance, container processing, facility design,

Company
Martin Avenue Pharmacy, Inc.
Inspection date
July 21, 2014
Product type
Drugs
Office
Chicago District Office
Person
  • Steven Barber (District Director at FDA)
View Company Profile

ID · 99745005-2f0f-4232-accf-cdd1a211335f

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 U.S.C. 353a(b)(1)(A)(i)(III)21 U.S.C. 353a21 U.S.C. 352(f)(1)21 U.S.C. 35521 U.S.C. 331(d)21 U.S.C. 331(k)21 U.S.C. 351(a)(2)(A)21 CFR 21021 CFR 211

Full citation text and observation details available on the Dashboard.

Other documents for Martin Avenue Pharmacy, Inc.
  • 483 - 2014-07-21July 21, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Martin Avenue Pharmacy, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.